Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters








Publication year range
1.
Behav Pharmacol ; 24(7): 569-79, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23994816

ABSTRACT

Bipolar disorder is a severe mood disorder with high morbidity and mortality. Despite adequate treatment, patients continue to have recurrent mood episodes, residual symptoms, and functional impairment. Some preclinical studies have shown that histone deacetylase inhibitors may act on depressive-like and manic-like behaviors. Therefore, the aim of the present study was to evaluate the effects of sodium butyrate (SB) on behavioral changes in animal models of depression and mania. The animals were submitted to protocols of chronic mild stress or maternal deprivation for induction of depressive-like behaviors and subjected to amphetamine, or ouabain administration for induction of manic-like behaviors. SB reversed the depressive-like and manic-like behaviors evaluated in the animal models. From these results we can suggest that SB may be a potential mood stabilizer.


Subject(s)
Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Butyric Acid/pharmacology , Affect/drug effects , Animals , Behavior, Animal/drug effects , Bipolar Disorder/physiopathology , Disease Models, Animal , Male , Rats , Rats, Wistar
2.
Neurosci Res ; 75(4): 324-30, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23416280

ABSTRACT

The rats were subjected to 40 days of stress protocol, during which the sucrose consumption was assessed in rats chronically treated with lamotrigine (20mg/kg) or with saline. The signaling cascade and oxidative stress parameters were assessed in the brain rat. Both control and stressed rats treated with lamotrigine showed an increase on malondialdehyde equivalents (MDA) in the prefrontal cortex, and that there was also an increase in the amygdala of the control rats treated with lamotrigine. The carbonyl protein was increased in the prefrontal cortex of the stressed group treated with saline, however, the lamotrigine treatment reversed this effect. The treatment with lamotrigine increased the superoxide dismutase (SOD) and catalase activity (CAT) activities in the amygdala of stressed rats. The protein kinase B (PKB/Akt) was reduced in the amygdala in the stressed group treated with saline or lamotrigine. We suggest that the antidepressant-like effect of lamotrigine on anhedonic behavior may be related at least in part to its effects on the oxidative stress parameters and AKT.


Subject(s)
Calcium Channel Blockers/pharmacology , Exploratory Behavior/drug effects , Oxidative Stress/drug effects , Signal Transduction/drug effects , Stress, Psychological/physiopathology , Triazines/pharmacology , Amygdala/drug effects , Amygdala/metabolism , Analysis of Variance , Animals , Calcium Channel Blockers/therapeutic use , Catalase/metabolism , Chronic Disease , Disease Models, Animal , Food Preferences/drug effects , Lamotrigine , Male , Malondialdehyde/metabolism , Protein Carbonylation/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Wistar , Stress, Psychological/drug therapy , Sucrose/administration & dosage , Superoxide Dismutase/metabolism , Sweetening Agents/administration & dosage , Thiobarbituric Acid Reactive Substances/metabolism , Triazines/therapeutic use
3.
Behav Brain Res ; 242: 40-6, 2013 Apr 01.
Article in English | MEDLINE | ID: mdl-23238043

ABSTRACT

A growing body of evidence is pointing toward an association between immune molecules, as well brain-derived neurotrophic factor (BDNF) and the depression. The present study was aimed to evaluate the behavioral and molecular effects of the antidepressant imipramine in maternally deprived adult rats. To this aim, maternally deprived and non-deprived (control group) male rats were treated with imipramine (30mg/kg) once a day for 14 days during their adult phase. Their behavior was then assessed using the forced swimming test. In addition to this, IL-10, TNF-α and IL-1ß cytokines were assessed in the serum and cerebrospinal fluid (CSF). In addition, BDNF protein levels were assessed in the prefrontal cortex, hippocampus and amygdala. In deprived rats treated with saline was observed an increase on immobility time, compared with non-deprived rats treated with imipramine (p<0.05). Deprived rats treated with saline presented a decrease on BDNF levels in the amygdala (p<0.05), compared with all other groups. The IL-10 levels were decreased in the serum (p<0.05). TNF-α and IL-1ß levels were increased in the serum and CSF of deprived rats treated with saline (p<0.05). Interestingly, imipramine treatment reversed the effects of maternal deprivation on BDNF and cytokines levels (p<0.05). Finally, these findings further support a relationship between immune activation, neurotrophins and the depression, and considering the action of imipramine, it is suggested that classic antidepressants could exert their effects by modulating the immune system.


Subject(s)
Antidepressive Agents, Tricyclic/administration & dosage , Brain-Derived Neurotrophic Factor/metabolism , Cytokines/metabolism , Gene Expression Regulation/drug effects , Imipramine/administration & dosage , Maternal Deprivation , Analysis of Variance , Animals , Brain/drug effects , Brain/metabolism , Female , Male , Pregnancy , Rats , Rats, Wistar
4.
Neurochem Int ; 61(7): 1072-80, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22898295

ABSTRACT

A growing body of evidence has pointed to a relationship between oxidative stress and depression. Thus, the present study was aimed at evaluating the effects of the antioxidants n-acetylcysteine (NAC), deferoxamine (DFX) or their combination on sweet food consumption and oxidative stress parameters in rats submitted to 40days of exposure to chronic mild stress (CMS). Our results showed that in stressed rats treated with saline, there was a decrease in sweet food intake and treatment with NAC or NAC in combination with DFX reversed this effect. Treatment with NAC and DFX decreased the oxidative damage, which include superoxide and TBARS production in submitochondrial particles, and also thiobarbituric acid reactive substances (TBARS) levels and carbonyl proteins in the prefrontal cortex, amygdala and hippocampus. Treatment with NAC and DFX also increased the activity of the antioxidant enzymes, superoxide dismutase and catalase in the same brain areas. Even so, a combined treatment with NAC and DFX produced a stronger increase of antioxidant activities in the prefrontal cortex, amygdala and hippocampus. The results described here indicate that co-administration may induce a more pronounced antidepressant activity than each treatment alone. In conclusion, these results suggests that treatment with NAC or DFX alone or in combination on oxidative stress parameters could have positive effects against neuronal damage caused by oxidative stress in major depressive disorders.


Subject(s)
Acetylcysteine/pharmacology , Behavior, Animal/drug effects , Deferoxamine/pharmacology , Oxidative Stress/drug effects , Stress, Psychological/psychology , Animals , Drug Synergism , Rats , Stress, Psychological/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
5.
Behav Brain Res ; 233(2): 526-35, 2012 Aug 01.
Article in English | MEDLINE | ID: mdl-22659397

ABSTRACT

The present study was aimed at investigating the behavioral and molecular effects of tianeptine. To this aim, Wistar rats were treated with tianeptine (5, 10 and 15 mg/kg) or imipramine (30 mg/kg) acutely and chronically. The results showed that both treatments reduced the immobility time. The BDNF levels were increased in the prefrontal cortex with tianeptine and decreased in the nucleus accumbens after acute treatment; in chronic treatment, BDNF levels were increased in the prefrontal and hippocampus with tianeptine. Acute treatment decreased the citrate synthase activity in the prefrontal cortex with tianeptine, and increased it in the amygdala with imipramine; chronic treatment increased the citrate synthase in the hippocampus with tianeptine. The creatine kinase was increased in the prefrontal cortex with tianeptine and in the amygdala with imipramine after acute treatment; chronic treatment increased the creatine kinase activity in the hippocampus with imipramine and tianeptine. The complex I activity was decreased in the prefrontal cortex with imipramine and increased in the hippocampus with tianeptine. The other complexes were increased with imipramine and tianeptine at all doses, but were related to the treatment given and the brain area studied. Chronic treatment increased the malate dehydrogenase activity in the amygdala with tianeptine. Acute treatment decreased the succinate activity in the prefrontal cortex, hippocampus and amygdala with tianeptine; chronic treatment increased the succinate activity in the hippocampus with tianeptine at all doses. In conclusion, tianeptine exerted antidepressant-like behavior which can be attributed to its effects on pathways related to depression, such as BDNF and metabolism energy.


Subject(s)
Antidepressive Agents/pharmacology , Brain-Derived Neurotrophic Factor/metabolism , Brain/drug effects , Brain/metabolism , Energy Metabolism/drug effects , Thiazepines/pharmacology , Analysis of Variance , Animals , Citrate (si)-Synthase , Creatine Kinase , Dose-Response Relationship, Drug , Electron Transport Chain Complex Proteins/metabolism , Exploratory Behavior/drug effects , Freezing Reaction, Cataleptic/drug effects , Imipramine/pharmacology , Male , Rats , Rats, Wistar , Swimming/psychology
6.
Exp Diabetes Res ; 2012: 302682, 2012.
Article in English | MEDLINE | ID: mdl-22645603

ABSTRACT

Diabetes Mellitus (DM) is associated with pathological changes in the central nervous system (SNC) as well as alterations in oxidative stress. Thus, the main objective of this study was to evaluate the effects of the animal model of diabetes induced by alloxan on memory and oxidative stress. Diabetes was induced in Wistar rats by using a single injection of alloxan (150 mg/kg), and fifteen days after induction, the rats memory was evaluated through the use of the object recognition task. The oxidative stress parameters and the activity of antioxidant enzymes, superoxide dismutase (SOD), and catalase (CAT) were measured in the rat brain. The results showed that diabetic rats did not have alterations in their recognition memory. However, the results did show that diabetic rats had increases in the levels of superoxide in the prefrontal cortex, and in thiobarbituric acid reactive species (TBARS) production in the prefrontal cortex and in the amygdala in submitochondrial particles. Also, there was an increase in protein oxidation in the hippocampus and striatum, and in TBARS oxidation in the striatum and amygdala. The SOD activity was decreased in diabetic rats in the striatum and amygdala. However, the CAT activity was increased in the hippocampus taken from diabetic rats. In conclusion, our findings illustrate that the animal model of diabetes induced by alloxan did not cause alterations in the animals' recognition memory, but it produced oxidants and an imbalance between SOD and CAT activities, which could contribute to the pathophysiology of diabetes.


Subject(s)
Alloxan/pharmacology , Antioxidants/metabolism , Brain/metabolism , Oxidative Stress , Animals , Catalase/biosynthesis , Corpus Striatum/metabolism , Diabetes Mellitus, Experimental/chemically induced , Hippocampus/metabolism , Male , Mitochondria/metabolism , Oxidants/metabolism , Oxygen/metabolism , Rats , Rats, Wistar , Superoxide Dismutase/biosynthesis , Thiobarbituric Acid Reactive Substances/metabolism , Time Factors
7.
J Psychiatr Res ; 46(8): 1029-35, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22575330

ABSTRACT

Recently, several studies have emerged suggesting a role of the intracellular survival pathways in the treatment of mood disorders. In addition, the beneficial effects of using a combination of antipsychotics and antidepressants have been shown. With this in mind, we evaluated the effects of the acute administration of fluoxetine (FLX), olanzapine (OLZ) and the combination of fluoxetine/olanzapine on the brain-derived-neurotrophic factor (BDNF), cAMP response element-binding (CREB), Protein Kinase B (PKB, Akt), B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated death promoter (BAD) in the rat brain. Adult Wistar rats received an acute injection of OLZ (3 or 6 mg/kg) and/or FLX (12.5 or 25 mg/kg), and were evaluated for Akt, BDNF, CREB, Bcl-2 and BAD protein levels in the prefrontal cortex, hippocampus and striatum. Our results showed that treatment with FLX and OLZ alone or in combination increased the Akt, CREB, BDNF, Bcl-2 and BAD levels in the prefrontal cortex, hippocampus and striatum. However, the combination of FLX and OLZ at high doses was associated with a greater increase in the levels of Akt in the prefrontal cortex, and did not have an effect on the levels of BAD in any of the brain areas that we evaluated. Finally, these findings further support the hypothesis that treatment with FLX and OLZ alone or in combination exert neuroprotective effects, and that intracellular survival pathways could be involved in the therapeutic effects of combining antipsychotic and antidepressant drugs in mood disorders.


Subject(s)
Benzodiazepines/administration & dosage , Fluoxetine/administration & dosage , Neuroprotective Agents/administration & dosage , Selective Serotonin Reuptake Inhibitors/administration & dosage , Signal Transduction/drug effects , Animals , Brain-Derived Neurotrophic Factor/metabolism , Cyclic AMP Response Element-Binding Protein/metabolism , Dose-Response Relationship, Drug , Drug Combinations , Drug Synergism , Male , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Wistar , bcl-Associated Death Protein/metabolism
8.
Diabetes Metab Res Rev ; 28(2): 139-44, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22423384

ABSTRACT

BACKGROUND: A growing body of evidence has shown an association between diabetes and depression, as well a role of brain-derived neurotrophic factor (BDNF) in diabetes and depression. The present study was designed to evaluate the behavioural and molecular effects of the anti-depressant imipramine in diabetic rats. METHODS: To this aim, after induction of diabetes by alloxan (150 mg/kg), Wistar rats were treated with imipramine (30 mg/kg) once a day for 14 days and then subjected to behavioural tests. BDNF was then assessed in the prefrontal cortex, hippocampus and amygdala. RESULTS: In diabetic rats treated with saline, we observed an increase in the immobility time, compared with control rats treated with saline. Treatment with imipramine decreased the immobility time in nondiabetic and diabetic rats, compared with both nondiabetic and diabetic rats treated with saline. In the open-field test, it was observed that treatment with imipramine reduced the number of crossings the diabetic rats performed, compared with nondiabetic rats treated with saline. The number of rearings did not alter in any of the groups. Diabetic rats injected with saline did not show altered BDNF levels in the prefrontal cortex, hippocampus or amygdala, but interestingly, the treatment with imipramine in diabetic animals increased BDNF levels in the prefrontal cortex. CONCLUSIONS: In conclusion, this study demonstartes a link between diabetes and depression in rats and that imipramine exerted antidepressant effects in diabetic animals.


Subject(s)
Antidepressive Agents/therapeutic use , Behavior, Animal/drug effects , Depressive Disorder/drug therapy , Diabetes Mellitus, Experimental/complications , Imipramine/therapeutic use , Alloxan , Amygdala/drug effects , Amygdala/metabolism , Animals , Brain-Derived Neurotrophic Factor/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Male , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Rats, Wistar
9.
Pharmacol Biochem Behav ; 101(3): 348-53, 2012 May.
Article in English | MEDLINE | ID: mdl-22306746

ABSTRACT

Lamotrigine is an anticonvulsant and has an antiglutamatergic action, which may contribute to its antidepressant effects, since glutamate has been linked to depression. The purpose of the present study was to investigate the behavioral and molecular effects of lamotrigine treatment in maternally deprived rats. To this aim, deprived and non-deprived male rats were treated with lamotrigine (20 mg/kg) once a day for 14 days during their adult phase. Their behavior was then assessed in the forced swimming and open field tests. In addition to this, the BDNF and NGF levels were assessed in the prefrontal cortex, hippocampus and amygdala. In the course of this study we demonstrated that maternally deprived rats treated with saline and lamotrigine showed an increase in their immobility time and a decrease in the climbing and swimming times when compared with non-deprived rats treated with saline alone. Treatment with lamotrigine reversed the increase in the immobility time in the deprived rats. The BDNF levels were decreased in the amygdala in deprived rats treated with saline, and treatment with lamotrigine reversed this decrease. The NGF levels were decreased in the hippocampus in deprived rats treated with saline, but treatment with lamotrigine did not reverse this decrease. In conclusion, lamotrigine showed antidepressant effects in the forced swimming test, and it presented positive effects on the BDNF protein levels in the amygdala of maternally deprived rats.


Subject(s)
Antidepressive Agents/pharmacology , Brain-Derived Neurotrophic Factor/metabolism , Brain/metabolism , Depression/etiology , Triazines/pharmacology , Amygdala/drug effects , Amygdala/metabolism , Animals , Behavior, Animal/drug effects , Brain/drug effects , Brain-Derived Neurotrophic Factor/deficiency , Depression/metabolism , Depression/psychology , Disease Models, Animal , Female , Hippocampus/drug effects , Hippocampus/metabolism , Lamotrigine , Male , Maternal Deprivation , Nerve Growth Factor/metabolism , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Pregnancy , Rats , Rats, Wistar
10.
Neurochem Int ; 59(8): 1163-74, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22044672

ABSTRACT

The present study was aimed to investigate the behavioral and molecular effects of lamotrigine. To this aim, Wistar rats were treated with lamotrigine (10 and 20 mg/kg) or imipramine (30 mg/kg) acutely and chronically. The behavior was assessed using forced swimming test. Brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), Proteina Kinase B (PKB, AKT), glycogen synthase kinase 3 (GSK-3) and B-cell lymphoma 2 (Bcl-2) levels, citrate synthase, creatine kinase and mitochondrial chain (I, II, II-III and IV) activities were assessed in the brain. The results showed that both treatments reduced the immobility time. The BDNF were increased in the prefrontal after acute treatment with lamotrigine (20 mg/kg), and the BDNF and NGF were increased in the prefrontal after chronic treatment with lamotrigine in all doses. The AKT increased and Bcl-2 and GSK-3 decreased after both treatments in all brain areas. The citrate synthase and creatine kinase increased in the amygdala after acute treatment with imipramine. Chronic treatment with imipramine and lamotrigine (10 mg/kg) increased the creatine kinase in the hippocampus. The complex I was reduced and the complex II, II-III and IV were increased, but related with treatment and brain area. In conclusion, lamotrigine exerted antidepressant-like, which can be attributed to its effects on pathways related to depression, such as neurotrophins, metabolism energy and signaling cascade.


Subject(s)
Antidepressive Agents/pharmacology , Brain/drug effects , Energy Metabolism/drug effects , Nerve Growth Factors/metabolism , Triazines/pharmacology , Animals , Antidepressive Agents/administration & dosage , Behavior, Animal/drug effects , Brain/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Glycogen Synthase Kinase 3/metabolism , Lamotrigine , Male , Nerve Growth Factor/metabolism , Rats , Rats, Wistar , Triazines/administration & dosage , Triazines/therapeutic use
11.
Neurosci Lett ; 497(2): 99-103, 2011 Jun 22.
Article in English | MEDLINE | ID: mdl-21545827

ABSTRACT

Evidence is emerging for a role for neurotrophins in the treatment of mood disorders. In this study, we evaluated the effects of chronic administration of fluoxetine, olanzapine and the combination of fluoxetine/olanzapine on the brain-derived-neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-3 (NT-3) in the rat brain. Wistar rats received daily injections of olanzapine (3 or 6 mg/kg) and/or fluoxetine (12.5 or 25mg/kg) for 28 days, and we evaluated for BDNF, NGF and NT-3 protein levels in the prefrontal cortex, hippocampus and amygdala. Our results showed that treatment with fluoxetine and olanzapine alone or in combination did not alter BDNF in the prefrontal cortex (p=0.37), hippocampus (p=0.98) and amygdala (p=0.57) or NGF protein levels in the prefrontal cortex (p=0.72), hippocampus (p=0.23) and amygdala (p=0.64), but NT-3 protein levels were increased by olanzapine 6 mg/kg/fluoxetine 25mg/kg combination in the prefrontal cortex (p=0.03), in the hippocampus (p=0.83) and amygdala (p=0.88) NT-3 protein levels did not alter. Finally, these findings further support the hypothesis that NT-3 could be involved in the effect of treatment with antipsychotic and antidepressant combination in mood disorders.


Subject(s)
Benzodiazepines/pharmacology , Fluoxetine/pharmacology , Neurotrophin 3/biosynthesis , Prefrontal Cortex/drug effects , Up-Regulation/drug effects , Up-Regulation/physiology , Animals , Antipsychotic Agents/pharmacology , Drug Synergism , Drug Therapy, Combination/methods , Male , Neurotrophin 3/metabolism , Olanzapine , Prefrontal Cortex/metabolism , Rats , Rats, Wistar , Selective Serotonin Reuptake Inhibitors/pharmacology
12.
Behav Brain Res ; 221(1): 166-71, 2011 Aug 01.
Article in English | MEDLINE | ID: mdl-21397634

ABSTRACT

A growing body of evidence has pointed to the N-methyl-d-aspartate (NMDA) receptor antagonists as a potential therapeutic target for the treatment of major depression. The present study investigated the possibility of synergistic interactions between antidepressant imipramine with the uncompetitive NMDA receptor antagonist ketamine. Wistar rats were acutely treated with ketamine (5 and 10mg/kg) and imipramine (10 and 20mg/kg) and then subjected to forced swimming tests. The cAMP response element bindig (CREB) and brain-derived neurotrophic factor (BDNF) protein levels and protein kinase C (PKC) and protein kinase A (PKA) phosphorylation were assessed in the prefrontal cortex, hippocampus and amygdala by imunoblot. Imipramine at the dose of 10mg/kg and ketamine at the dose of 5mg/kg did not have effect on the immobility time; however, the effect of imipramine (10 and 20mg/kg) was enhanced by both doses of ketamine. Ketamine and imipramine alone or in combination at all doses tested did not modify locomotor activity. Combined treatment with ketamine and imipramine produced stronger increases of CREB and BDNF protein levels in the prefrontal cortex, hippocampus and amygdala, and PKA phosphorylation in the hippocampus and amygdala and PKC phosphorylation in prefrontal cortex. The results described indicate that co-administration of antidepressant imipramine with ketamine may induce a more pronounced antidepressant activity than treatment with each antidepressant alone. This finding may be of particular importance in the case of drug-resistant patients and could suggest a method of obtaining significant antidepressant actions whilst limiting side effects.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Brain/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Depression/drug therapy , Imipramine/therapeutic use , Ketamine/therapeutic use , Protein Kinase C/metabolism , Animals , Antidepressive Agents/administration & dosage , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Brain/metabolism , Depression/metabolism , Disease Models, Animal , Drug Evaluation, Preclinical , Drug Synergism , Drug Therapy, Combination , Imipramine/administration & dosage , Imipramine/pharmacology , Immobility Response, Tonic/drug effects , Ketamine/administration & dosage , Ketamine/pharmacology , Motor Activity/drug effects , Phosphorylation , Rats , Rats, Wistar
15.
Neurosci Lett ; 487(3): 278-81, 2011 Jan 10.
Article in English | MEDLINE | ID: mdl-20971158

ABSTRACT

A growing body of evidence has indicated that energy metabolism impairment may be involved in pathophysiology of some neuropsychiatric disorders. In this study, we evaluated the effect of acute and chronic administration of fluoxetine, olanzapine and the combination of fluoxetine/olanzapine on citrate synthase activity in brain of rats. For acute treatment, Wistar rats received one single injection of olanzapine (3 or 6mg/kg) and/or fluoxetine (12.5 or 25mg/kg). For chronic treatment, rats received daily injections of olanzapine (3 or 6mg/kg) and/or fluoxetine (12.5 or 25mg/kg) for 28 days. In the present study we observed that acute administration of olanzapine inhibited citrate synthase activity in cerebellum and prefrontal cortex. The acute administration of olanzapine increased citrate synthase activity in prefrontal cortex, hippocampus and striatum and fluoxetine increased citrate synthase activity in striatum. Olanzapine 3mg/kg and fluoxetine 12.5mg/kg in combination increased citrate synthase activity in prefrontal cortex, hippocampus and striatum. In the chronic treatment we did not observed any effect on citrate synthase activity. Our results showed that olanzapine and fluoxetine increased citrate synthase activity after acute, but not chronic treatment.


Subject(s)
Benzodiazepines/pharmacology , Brain/drug effects , Citrate (si)-Synthase/drug effects , Fluoxetine/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Animals , Brain/enzymology , Citrate (si)-Synthase/metabolism , Male , Olanzapine , Rats , Rats, Wistar
16.
Neurochem Res ; 36(3): 460-6, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21161589

ABSTRACT

The present study was aimed to evaluate the behavioral and molecular effects of maternal deprivation in adult rats. To this aim, male rats deprived and non-deprived were assessed in the forced swimming and open-field tests in adult phase. In addition adrenocorticotrophin hormone (ACTH) levels was assessed in serum and brain-derived-neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and nerve growth factor (NGF) protein levels were assessed in prefrontal cortex, hippocampus and amygdala. We observed that maternal deprivation increased immobility time, and decreased climbing time, without affecting locomotor activity. ACTH circulating levels were increased in maternal deprived rats. Additionally, BDNF protein levels were reduced in the amygdala and NT-3 and NGF were reduced in both hippocampus and amygdala in maternal deprived rats, compared to control group. In conclusion, our results support the idea that behavioral, ACTH circulating levels and neurotrophins levels altered in maternal deprivation model could contribute to stress-related diseases, such as depression.


Subject(s)
Brain/metabolism , Depression/metabolism , Maternal Deprivation , Nerve Growth Factors/metabolism , Animals , Brain/anatomy & histology , Child , Depression/physiopathology , Female , Humans , Male , Neuropsychological Tests , Pregnancy , Rats , Rats, Wistar , Swimming
SELECTION OF CITATIONS
SEARCH DETAIL